Cargando…
A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
In conjunction with rehydration, the bisphosphonates are the treatment of choice for hypercalcaemia of malignancy. Single infusions of either pamidronate or clodronate are usually effective, but a direct comparison of the two agents given at the highest doses commonly used has not been performed. Fo...
Autores principales: | Purohit, O. P., Radstone, C. R., Anthony, C., Kanis, J. A., Coleman, R. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033943/ https://www.ncbi.nlm.nih.gov/pubmed/7577484 |
Ejemplares similares
-
Treatment of malignant hypercalcaemia with clodronate.
por: Percival, R. C., et al.
Publicado: (1985) -
Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
por: O'Rourke, N. P., et al.
Publicado: (1993) -
High-dose intravenous pamidronate for metastatic bone pain.
por: Purohit, O. P., et al.
Publicado: (1994) -
Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
por: Ling, P. J., et al.
Publicado: (1995) -
Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
por: Shah, S, et al.
Publicado: (2002)